Login to Your Account

Acambis' MVA Smallpox Vaccine Out Of Running For U.S. Contract

By Jennifer Boggs

Wednesday, November 15, 2006
Shares of Acambis plc plunged 40 percent on news that the U.S. Department of Health and Human Services (HHS) rejected the company's proposal to provide 20 million doses of its modified vaccinia ankara (MVA) smallpox vaccine. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription